Skip to main content
FDA Shortage Check

Is Furosemide Injection in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Furosemide Injection: in shortage

Injections (vials)
A generic injection, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Demand increase for the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Reason: “Discontinuation of the manufacture of the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Estimate: “Estimated recovery: TBD/ NDC non-Exempt”. Manufacturer’s estimate, Accord Healthcare Inc., Oct 17, 2026
DRUG
Furosemide Injection
FDA LISTING
FORM
injection
STATUS
Currently in Shortage
FIRST POSTED
Apr 7, 2020
LAST FDA UPDATE
Oct 21, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 27 presentations: 11 unavailable · 0 limited · 16 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Furosemide Injection. 30 presentations from 8 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Accord Healthcare Inc.3 presentations · 3 unavailable

Contact (FDA's listing): 866-941-7875

  • 10 mg/1 mL

    Furosemide, Injection, 10 mg/1 mL (NDC 16729-500-08)

    Estimated recovery: TBD/ NDC non-Exempt

    NDC 16729-500-08Reverified

    Unavailable

  • 10 mg/1 mL

    Furosemide, Injection, 10 mg/1 mL (NDC 16729-501-43)

    Estimated recovery: TBD/ NDC non-Exempt

    NDC 16729-501-43Reverified

    Unavailable

  • 10 mg/1 mL

    Furosemide, Injection, 10 mg/1 mL (NDC 16729-502-43)

    Estimated recovery: TBD/ NDC non-Exempt

    NDC 16729-502-43Reverified

    Unavailable

Avet Pharmaceuticals, Inc.3 presentations · 1 unavailable · 2 available or not stated

Contact (FDA's listing): 855-228-9470

  • 10 mg/1 mL

    Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-44)

    Estimated recovery: end October 2026

    NDC 23155-473-44Reverified

    Unavailable

  • 10 mg/1 mL

    Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-41)

    NDC 23155-473-41Reverified

    Available

  • 10 mg/1 mL

    Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-42)

    NDC 23155-473-42Reverified

    Available

Eugia US LLC3 presentations · 1 unavailable · 2 available or not stated

Contact (FDA's listing): 888-238-7880

  • 20 mg/2 mL

    Furosemide, Injection, 20 mg/2 mL (NDC 55150-322-25)

    On backorder. Recovery: TBD. Check wholesalers for inventory

    NDC 55150-322-25Reverified

    Unavailable

  • 100 mg/10 mL

    Furosemide, Injection, 100 mg/10 mL (NDC 55150-324-25)

    Check wholesalers for inventory

    NDC 55150-324-25Reverified

    Available

  • 40 mg/4 mL

    Furosemide, Injection, 40 mg/4 mL (NDC 55150-323-25)

    Check wholesalers for inventory

    NDC 55150-323-25Reverified

    Available

Gland Pharma Limited3 presentations · 3 unavailable

Contact (FDA's listing): 866-625-1618

  • 10 mg/1 mL

    Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-02)

    Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product

    NDC 25021-311-02Reverified

    Unavailable

  • 10 mg/1 mL

    Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-04)

    Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product

    NDC 25021-311-04Reverified

    Unavailable

  • 10 mg/1 mL

    Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-10)

    Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product

    NDC 25021-311-10Reverified

    Unavailable

Hospira, Inc., a Pfizer Company6 presentations · 3 unavailable · 3 available or not stated

Contact (FDA's listing): 844-646-4398

  • 100 mg/ 10mL (10 mg/1 mL)

    Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-27)

    Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay

    NDC 0409-6102-27Revised

    Unavailable

  • 20 mg/2 mL (10 mg/1 mL)

    Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-25)

    Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay

    NDC 0409-6102-25Revised

    Unavailable

  • 40 mg/4 mL (10 mg/1 mL)

    Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-26)

    Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay

    NDC 0409-6102-26Revised

    Unavailable

  • 100 mg/ 10mL (10 mg/1 mL)

    Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-10)

    NDC 0409-6102-10Reverified

    Available

  • 20 mg/2 mL (10 mg/1 mL)

    Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-02)

    NDC 0409-6102-02Reverified

    Available

  • 40 mg/4 mL (10 mg/1 mL)

    Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-04)

    NDC 0409-6102-04Reverified

    Available

Baxter Healthcare3 presentations · 3 available or not stated

Contact (FDA's listing): 888-229-0001

  • 10 mg/1 mL

    Furosemide, Injection, 10 mg/1 mL (NDC 36000-282-25)

    NDC 36000-282-25Reverified

    Available

  • 10 mg/1 mL

    Furosemide, Injection, 10 mg/1 mL (NDC 36000-283-25)

    NDC 36000-283-25Reverified

    Available

  • 10 mg/1 mL

    Furosemide, Injection, 10 mg/1 mL (NDC 36000-284-25)

    NDC 36000-284-25Reverified

    Available

Fresenius Kabi USA, LLC3 presentations · 3 available or not stated

Contact (FDA's listing): 888-386-1300

  • 10 mg/1 mL

    Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-02)

    Check wholesalers for inventory

    NDC 63323-280-02Reverified

    Available

  • 10 mg/1 mL

    Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-04)

    Check wholesalers for inventory

    NDC 63323-280-04Reverified

    Available

  • 10 mg/1 mL

    Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-10)

    Check wholesalers for inventory

    NDC 63323-280-10Reverified

    Available

Meitheal Pharmaceuticals, Inc.3 presentations · 3 available or not stated

Contact (FDA's listing): 844-824-8426

  • 10 mg/1 mL

    Furosemide, Injection, 10 mg/1 mL (NDC 71288-203-05)

    Check wholesalers for inventory

    NDC 71288-203-05Reverified

    Available

  • 10 mg/1 mL

    Furosemide, Injection, 10 mg/1 mL (NDC 71288-203-11)

    Check wholesalers for inventory

    NDC 71288-203-11Reverified

    Available

  • 10 mg/mL, 2 mL

    Furosemide, Injection, 10 mg/mL, 2 mL (NDC 71288-205-03)

    Check wholesalers for inventory

    NDC 71288-205-03Reverified

    Available

What the manufacturers told FDA

  • Accord Healthcare Inc. · ‘Estimated recovery: TBD/ NDC non-Exempt’ · updated Oct 2026
  • Avet Pharmaceuticals, Inc. · ‘Estimated recovery: end October 2026’ · updated Oct 2026
  • Eugia US LLC · ‘On backorder. Recovery: TBD. Check wholesalers for inventory’ · updated Oct 2026
  • Hospira, Inc., a Pfizer Company · ‘Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay’ · updated Oct 2026
  • Hospira, Inc., a Pfizer Company · ‘Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay’ · updated Oct 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Demand increase for the drug
  • Discontinuation of the manufacture of the drug
  • Other
  • Requirements related to complying with good manufacturing practices

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Other products with the same ingredient and form

A discontinuation “does not necessarily create a shortage” (FDA).

  • Gland Pharma Limited told FDA it will discontinue Furosemide (posted ).

    “Distributed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug”

    FDA listing: Furosemide Injection

Shown as FDA status, not as suggestions.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Furosemide Injection in shortage?
Yes. As of Oct 24, 2026, FDA lists Furosemide Injection as currently in shortage: 27 presentations, 11 unavailable and 0 limited.
When will the Furosemide Injection shortage end?
FDA gives no end date. 7 presentations carry a manufacturer’s own estimate, quoted on this page with its date.
Does FDA list alternatives to Furosemide Injection?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.